Form 4 for SRTA Strata Critical Medical, Inc.
Accepted 2022-06-03 00:00:00 ET · period of report 2022-05-05 · accession 0001924934-22-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-03 | 2022-05-05 | SRTA | Arkhipenko Anatoli | CTO | A - Grant | $0.00 | +43.0K | 43.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A common stock, $0.0001 par value per share | 2022-05-05 | A | A | 43,017 | $0.00 | 43,017 | D | — | — | (F1) Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting. The RSUs will vest over 48 months, with 25% (rounded down to the nearest whole number) vesting on April 11, 2023, and 6.25% (rounded down to the nearest whole number) vesting every three months following April 11, 2023, with any remainder to vest on April 11, 2026, such that 100% will be vested on April 11, 2026, subject to the Reporting Person's continued service to the Issuer. |